Please upgrade your browser

We built this website using the latest browser technologies to deliver the very best experience.

This makes the site run faster and easier to use. Unfortunately, your browser is out of date and will not support some of these technologies.

We recommend that you use a modern browser such as Google Chrome or Microsoft Edge to view this website.

Download ChromeDownload Microsoft Edge
Press release

Results of General Meeting

Sensyne Health plc today announces that at the General Meeting held earlier today all resolutions proposed were duly passed by shareholders.

June 6, 2022

The full text of the resolutions is set out in the Notice of General Meeting in Part IV of the Circular which was sent to shareholders on 18 May 2022 (the “Circular”) and is available from the Company’s website at https://www.sensynehealth.com/investors/shareholder-information

Terms used in this announcement shall be as defined in the Circular unless the context requires otherwise. 

Voting on the resolutions was conducted by way of a poll and a summary of the votes received is as follows: 

Res No.* Votes For % Votes Against % Votes Total % of ISC Votes Withheld***
1. Approval of the Sub-division of the Ordinary Shares 94,932,989 94.99% 5,002,018 5.01% 99,935,007 60.12 3,060,310
2. Amend the Articles to include the rights of Deferred Shares 94,832,989 94.99% 5,002,018 5.01% 99,935,007 60.06 3,060,310
3. Authority to convert Loan Notes into Ordinary Shares
94,832,989 94.99% 5,002,018 5.01% 99,935,007 60.06 3,060,310
4. Disapplication of pre-emption rights in respect of conversion of Loan Notes into Ordinary Shares
94,832,989 94.99% 5,002,018 5.01% 99,935,007 60.06 3,060,310
5. Authority to issue Warrants to subscribe for Ordinary Shares 94,932,989 94.99% 5,002,018 5.01% 99,935,007 60.12 3,060,310
6. Disapplication of pre-emption rights in respect of
the issue of the Warrants
94,932,989 94.99% 5,002,018 5.01% 99,935,007 60.12 3,060,310
7. Approve the waiver granted by the Takeover Panel of the obligation under Rule 9 of the Takeover Code** 63,035,642 96.20% 2,487,708 3.80% 65,523,350 39.42 3,118,462
8. Cancellation of the admission to trading on AIM per Rule 41 of the AIM Rules 95,131,382 92.47% 7,746,581 7.53% 102,877,963 61.89 117,354
9. Approval of the Re-registration of
the Company as a private company
94,975,899 95.09% 4,899,654 4.91% 99,875,553 60.08 3,119,764
10. Adopt the New Articles upon the Re-registration 94,975,899 95.09% 4,899,654 4.91% 99,875,553 60.08 3,119,764

* Resolutions numbered 1, 3, 5 and 7 were proposed and passed as ordinary resolutions and resolutions numbered 2, 4, 6, 8, 9 and 10 were proposed and passed as special resolutions. 

** In accordance with the Takeover Code, the Rule 9 Waiver Resolution (resolution 7) was taken on a poll of Independent Shareholders. 

***A vote withheld is not a vote in law and means the percentage of votes cast for and against excludes withheld votes. 

As at 31 May 2022, the Company’s issued share capital comprised of 166,464,335 Ordinary Shares, with each such Ordinary Share carrying the right to one vote. The total voting rights of the Company on the day on which shareholders had to be on the register of members in order to be eligible to vote at the General Meeting was 166,464,335. 


Expected timetable for Delisting and Re-registration 

The Company confirms that, as at today’s date, the expected timetable for the cancellation of the admission to trading on AIM of the Company's Ordinary Shares is as follows: 

Event* Date**
Last day of dealings on AIM in the Ordinary Shares 17 June 2022
Cancellation of the admission to trading on AIM of the
Ordinary Shares
7.00 a.m. on 20 June 2022
Re-registration as a private limited company On or around 4 July 2022

* Each of the times and dates set out in the above timetable are subject to change by the Company, in which event details of the new times and dates will be notified to London Stock Exchange plc and the Company will make an appropriate announcement to a Regulatory Information Service. 

** References to times are to London time.

Press release

Results of General Meeting

June 6, 2022
Sensyne Health plc today announces that at the General Meeting held earlier today all resolutions proposed were duly passed by shareholders.

The full text of the resolutions is set out in the Notice of General Meeting in Part IV of the Circular which was sent to shareholders on 18 May 2022 (the “Circular”) and is available from the Company’s website at https://www.sensynehealth.com/investors/shareholder-information

Terms used in this announcement shall be as defined in the Circular unless the context requires otherwise. 

Voting on the resolutions was conducted by way of a poll and a summary of the votes received is as follows: 

Res No.* Votes For % Votes Against % Votes Total % of ISC Votes Withheld***
1. Approval of the Sub-division of the Ordinary Shares 94,932,989 94.99% 5,002,018 5.01% 99,935,007 60.12 3,060,310
2. Amend the Articles to include the rights of Deferred Shares 94,832,989 94.99% 5,002,018 5.01% 99,935,007 60.06 3,060,310
3. Authority to convert Loan Notes into Ordinary Shares
94,832,989 94.99% 5,002,018 5.01% 99,935,007 60.06 3,060,310
4. Disapplication of pre-emption rights in respect of conversion of Loan Notes into Ordinary Shares
94,832,989 94.99% 5,002,018 5.01% 99,935,007 60.06 3,060,310
5. Authority to issue Warrants to subscribe for Ordinary Shares 94,932,989 94.99% 5,002,018 5.01% 99,935,007 60.12 3,060,310
6. Disapplication of pre-emption rights in respect of
the issue of the Warrants
94,932,989 94.99% 5,002,018 5.01% 99,935,007 60.12 3,060,310
7. Approve the waiver granted by the Takeover Panel of the obligation under Rule 9 of the Takeover Code** 63,035,642 96.20% 2,487,708 3.80% 65,523,350 39.42 3,118,462
8. Cancellation of the admission to trading on AIM per Rule 41 of the AIM Rules 95,131,382 92.47% 7,746,581 7.53% 102,877,963 61.89 117,354
9. Approval of the Re-registration of
the Company as a private company
94,975,899 95.09% 4,899,654 4.91% 99,875,553 60.08 3,119,764
10. Adopt the New Articles upon the Re-registration 94,975,899 95.09% 4,899,654 4.91% 99,875,553 60.08 3,119,764

* Resolutions numbered 1, 3, 5 and 7 were proposed and passed as ordinary resolutions and resolutions numbered 2, 4, 6, 8, 9 and 10 were proposed and passed as special resolutions. 

** In accordance with the Takeover Code, the Rule 9 Waiver Resolution (resolution 7) was taken on a poll of Independent Shareholders. 

***A vote withheld is not a vote in law and means the percentage of votes cast for and against excludes withheld votes. 

As at 31 May 2022, the Company’s issued share capital comprised of 166,464,335 Ordinary Shares, with each such Ordinary Share carrying the right to one vote. The total voting rights of the Company on the day on which shareholders had to be on the register of members in order to be eligible to vote at the General Meeting was 166,464,335. 


Expected timetable for Delisting and Re-registration 

The Company confirms that, as at today’s date, the expected timetable for the cancellation of the admission to trading on AIM of the Company's Ordinary Shares is as follows: 

Event* Date**
Last day of dealings on AIM in the Ordinary Shares 17 June 2022
Cancellation of the admission to trading on AIM of the
Ordinary Shares
7.00 a.m. on 20 June 2022
Re-registration as a private limited company On or around 4 July 2022

* Each of the times and dates set out in the above timetable are subject to change by the Company, in which event details of the new times and dates will be notified to London Stock Exchange plc and the Company will make an appropriate announcement to a Regulatory Information Service. 

** References to times are to London time.

Press release

Results of General Meeting

Results of General Meeting

June 6, 2022
Sensyne Health plc today announces that at the General Meeting held earlier today all resolutions proposed were duly passed by shareholders.

The full text of the resolutions is set out in the Notice of General Meeting in Part IV of the Circular which was sent to shareholders on 18 May 2022 (the “Circular”) and is available from the Company’s website at https://www.sensynehealth.com/investors/shareholder-information

Terms used in this announcement shall be as defined in the Circular unless the context requires otherwise. 

Voting on the resolutions was conducted by way of a poll and a summary of the votes received is as follows: 

Res No.* Votes For % Votes Against % Votes Total % of ISC Votes Withheld***
1. Approval of the Sub-division of the Ordinary Shares 94,932,989 94.99% 5,002,018 5.01% 99,935,007 60.12 3,060,310
2. Amend the Articles to include the rights of Deferred Shares 94,832,989 94.99% 5,002,018 5.01% 99,935,007 60.06 3,060,310
3. Authority to convert Loan Notes into Ordinary Shares
94,832,989 94.99% 5,002,018 5.01% 99,935,007 60.06 3,060,310
4. Disapplication of pre-emption rights in respect of conversion of Loan Notes into Ordinary Shares
94,832,989 94.99% 5,002,018 5.01% 99,935,007 60.06 3,060,310
5. Authority to issue Warrants to subscribe for Ordinary Shares 94,932,989 94.99% 5,002,018 5.01% 99,935,007 60.12 3,060,310
6. Disapplication of pre-emption rights in respect of
the issue of the Warrants
94,932,989 94.99% 5,002,018 5.01% 99,935,007 60.12 3,060,310
7. Approve the waiver granted by the Takeover Panel of the obligation under Rule 9 of the Takeover Code** 63,035,642 96.20% 2,487,708 3.80% 65,523,350 39.42 3,118,462
8. Cancellation of the admission to trading on AIM per Rule 41 of the AIM Rules 95,131,382 92.47% 7,746,581 7.53% 102,877,963 61.89 117,354
9. Approval of the Re-registration of
the Company as a private company
94,975,899 95.09% 4,899,654 4.91% 99,875,553 60.08 3,119,764
10. Adopt the New Articles upon the Re-registration 94,975,899 95.09% 4,899,654 4.91% 99,875,553 60.08 3,119,764

* Resolutions numbered 1, 3, 5 and 7 were proposed and passed as ordinary resolutions and resolutions numbered 2, 4, 6, 8, 9 and 10 were proposed and passed as special resolutions. 

** In accordance with the Takeover Code, the Rule 9 Waiver Resolution (resolution 7) was taken on a poll of Independent Shareholders. 

***A vote withheld is not a vote in law and means the percentage of votes cast for and against excludes withheld votes. 

As at 31 May 2022, the Company’s issued share capital comprised of 166,464,335 Ordinary Shares, with each such Ordinary Share carrying the right to one vote. The total voting rights of the Company on the day on which shareholders had to be on the register of members in order to be eligible to vote at the General Meeting was 166,464,335. 


Expected timetable for Delisting and Re-registration 

The Company confirms that, as at today’s date, the expected timetable for the cancellation of the admission to trading on AIM of the Company's Ordinary Shares is as follows: 

Event* Date**
Last day of dealings on AIM in the Ordinary Shares 17 June 2022
Cancellation of the admission to trading on AIM of the
Ordinary Shares
7.00 a.m. on 20 June 2022
Re-registration as a private limited company On or around 4 July 2022

* Each of the times and dates set out in the above timetable are subject to change by the Company, in which event details of the new times and dates will be notified to London Stock Exchange plc and the Company will make an appropriate announcement to a Regulatory Information Service. 

** References to times are to London time.

Press release

Results of General Meeting

June 6, 2022
Sensyne Health plc today announces that at the General Meeting held earlier today all resolutions proposed were duly passed by shareholders.

The full text of the resolutions is set out in the Notice of General Meeting in Part IV of the Circular which was sent to shareholders on 18 May 2022 (the “Circular”) and is available from the Company’s website at https://www.sensynehealth.com/investors/shareholder-information

Terms used in this announcement shall be as defined in the Circular unless the context requires otherwise. 

Voting on the resolutions was conducted by way of a poll and a summary of the votes received is as follows: 

Res No.* Votes For % Votes Against % Votes Total % of ISC Votes Withheld***
1. Approval of the Sub-division of the Ordinary Shares 94,932,989 94.99% 5,002,018 5.01% 99,935,007 60.12 3,060,310
2. Amend the Articles to include the rights of Deferred Shares 94,832,989 94.99% 5,002,018 5.01% 99,935,007 60.06 3,060,310
3. Authority to convert Loan Notes into Ordinary Shares
94,832,989 94.99% 5,002,018 5.01% 99,935,007 60.06 3,060,310
4. Disapplication of pre-emption rights in respect of conversion of Loan Notes into Ordinary Shares
94,832,989 94.99% 5,002,018 5.01% 99,935,007 60.06 3,060,310
5. Authority to issue Warrants to subscribe for Ordinary Shares 94,932,989 94.99% 5,002,018 5.01% 99,935,007 60.12 3,060,310
6. Disapplication of pre-emption rights in respect of
the issue of the Warrants
94,932,989 94.99% 5,002,018 5.01% 99,935,007 60.12 3,060,310
7. Approve the waiver granted by the Takeover Panel of the obligation under Rule 9 of the Takeover Code** 63,035,642 96.20% 2,487,708 3.80% 65,523,350 39.42 3,118,462
8. Cancellation of the admission to trading on AIM per Rule 41 of the AIM Rules 95,131,382 92.47% 7,746,581 7.53% 102,877,963 61.89 117,354
9. Approval of the Re-registration of
the Company as a private company
94,975,899 95.09% 4,899,654 4.91% 99,875,553 60.08 3,119,764
10. Adopt the New Articles upon the Re-registration 94,975,899 95.09% 4,899,654 4.91% 99,875,553 60.08 3,119,764

* Resolutions numbered 1, 3, 5 and 7 were proposed and passed as ordinary resolutions and resolutions numbered 2, 4, 6, 8, 9 and 10 were proposed and passed as special resolutions. 

** In accordance with the Takeover Code, the Rule 9 Waiver Resolution (resolution 7) was taken on a poll of Independent Shareholders. 

***A vote withheld is not a vote in law and means the percentage of votes cast for and against excludes withheld votes. 

As at 31 May 2022, the Company’s issued share capital comprised of 166,464,335 Ordinary Shares, with each such Ordinary Share carrying the right to one vote. The total voting rights of the Company on the day on which shareholders had to be on the register of members in order to be eligible to vote at the General Meeting was 166,464,335. 


Expected timetable for Delisting and Re-registration 

The Company confirms that, as at today’s date, the expected timetable for the cancellation of the admission to trading on AIM of the Company's Ordinary Shares is as follows: 

Event* Date**
Last day of dealings on AIM in the Ordinary Shares 17 June 2022
Cancellation of the admission to trading on AIM of the
Ordinary Shares
7.00 a.m. on 20 June 2022
Re-registration as a private limited company On or around 4 July 2022

* Each of the times and dates set out in the above timetable are subject to change by the Company, in which event details of the new times and dates will be notified to London Stock Exchange plc and the Company will make an appropriate announcement to a Regulatory Information Service. 

** References to times are to London time.